IMO the two biggest take home points from this PR are as follows:
From about 2/3 the way through the 3rd paragraph:
And from the last sentence before the break into the "about Ampligen" description:
HEB may have something effective against Ebola,.... but they need to get it moved forward into testing pronto if they want to have an impact and leave a significant footprint on the market in preparation for the inevitable "next" Ebola outbreak.